Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)

Last Price0.5198

Change+0.1098 (26.78%)

NASDAQ · Last Trade: Apr 9th, 1:07 PM EDT

Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment

Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently

Via Spotlight Growth · May 22, 2023